Referred to committee
Summary
The bill sets up the Ohio‑Made Medicine Manufacturing Program, run by the Department of Administrative Services with help from the health and development departments, to purchase, make, and distribute generic drugs. It lets the program partner with insurers, state agencies, and other groups, set transparent prices, and focus on drugs for chronic and high‑cost conditions, aiming to cut costs for patients and taxpayers.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HB 892 changes status, plus AI-powered summaries and stage predictions.
Sign up free